Geron Reviews

Rating Trends
Recommend to a friend
Approve of CEO
Geron Director, President & CEO John A. Scarlett
John A. Scarlett
2 Ratings
  • This group is fantastic!

    • Work/Life Balance
    • Culture & Values
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Former Employee - Legal Intern in San Francisco, CA
    Former Employee - Legal Intern in San Francisco, CA
    Positive Outlook
    Approves of CEO

    I worked at Geron full-time (Less than a year)


    This company is full of wonderful people who all seem to work very well with one another, and it shows in the success they've had.


    They have had to reduce the number of employees since the recession, and I get the impression that it's a difficult thing for everyone involved, especially because everyone seems to appreciate each other. This is a con, but it has been a necessary con in response to challenging times or changes to the company's strategy.

    Advice to Management

    Keep perpetuating a friendly team environment

Geron Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Headquarters Menlo Park, CA
Size 1 to 50 Employees
Founded 1990
Type Company - Public (GERN)
Industry Biotech & Pharmaceuticals
Revenue $1 to $5 million (USD) per year

Geron is working to get important things into our thick heads -- more specifically, it is developing a compound able to penetrate the blood-brain barrier that otherwise keeps potentially valuable drugs out of the brain. The company's research and development is targeting viable therapies for cancer, injury, and degenerative diseases. One of the company's lead products in clinical trials is an hESC therapy (derived from human stem cells) called GRNOPC1 for spinal cord injury. Geron is also focused on anticancer drug candidate GRN163L, which inhibits telomerase, an ... More

Work at Geron? Share Your Experiences


Click to Rate